共 50 条
- [5] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer [J]. PharmacoEconomics, 2005, 23 : 69 - 75
- [7] Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5 [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5166 - 5170
- [10] Erratum to: Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer [J]. European Journal of Clinical Pharmacology, 1997, 51 : 427 - 427